Dual Inhibition of Ezh2 and Hdac Is Synergistic in Ezh2 Dysregulated Lymphomas
Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_120
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley
Available in full text
June 1, 2017
Wiley